Saturday 17 October 2026
Export CELC’s income statement to Excel — free account
Celcuity, Inc.
CELC Healthcare Biotechnology
In the quarter to June 2026, EPS fell 38.5%, free cash flow fell 53.3% and total debt rose 658.7%, each against the same quarter a year earlier.
56.16
4.14
−6.87%
Follow CELC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
13.27 | 42.35 | 38.08 | 21.12 | 10.26 | 34.06 | 25.46 | 13.43 | 7.71 | 10.55 |
Net Debt/EBITDA |
1.81 | 4.15 | 3.23 | 2.51 | 1.27 | 2.51 | 3.44 | 2.18 | 1.23 | 0.71 |
Debt/Assets |
0.00% | 0.00% | 0.08% | 0.07% | 0.06% | 17.03% | 19.91% | 19.37% | 39.87% | 68.98% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 | 0.26 | 0.27 | 0.85 | 3.20 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.87 | 0.79 | 0.81 | 0.82 | 0.75 | 0.69 | 0.89 | 0.84 | 0.75 | 0.87 |
Capex/Depreciation |
(0.56) | (2.29) | (2.81) | (1.12) | (0.23) | (0.14) | (0.26) | (0.25) | (0.17) | (0.08) |
Interest Coverage |
(184.91) | (13.18) | (79,325.00) | (39,026.50) | (95,562.00) | (22.46) | (18.70) | (12.43) | (11.02) | (10.04) |
| (62.30%) | (33.79%) | (26.37%) | (32.97%) | (61.12%) | (73.63%) | (39.88%) | (46.63%) | (87.54%) | (163.80%) | |
| (58.30%) | (32.88%) | (25.80%) | (31.78%) | (57.01%) | (59.89%) | (30.86%) | (34.76%) | (51.23%) | (49.75%) | |
ROIC |
0.00% | (52.07%) | (1,050.38%) | (845.90%) | (8,215.44%) | 0.00% | (14,733.36%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(58.99%) | (25.85%) | (29.49%) | (38.38%) | (82.09%) | (35.60%) | (23.95%) | (36.11%) | (52.43%) | (41.95%) |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.46) | (0.70) | (0.66) | (0.62) | (0.70) | (1.52) | (2.35) | (2.28) | (2.12) | (3.28) |
Cash per Share |
0.94 | 3.25 | 2.46 | 1.83 | 1.13 | 6.30 | 10.93 | 7.63 | 5.96 | 9.44 |
Shareholders Equity per Share |
0.89 | 4.21 | 2.50 | 1.89 | 1.14 | 5.13 | 8.68 | 5.90 | 2.93 | 2.15 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.89 | 4.21 | 2.50 | 1.89 | 1.14 | 5.13 | 8.68 | 5.90 | 2.93 | 2.15 |
Free Cash Flow |
(2.93) | (5.19) | (6.70) | (6.38) | (7.24) | (20.39) | (36.17) | (53.91) | (83.72) | (153.53) |
Working Capital |
5.47 | 23.91 | 24.56 | 18.34 | 10.98 | 82.85 | 168.31 | 176.40 | 212.85 | 421.51 |
Capital Expenditures |
(0.04) | (0.24) | (0.63) | (0.38) | (0.09) | (0.08) | (0.16) | (0.10) | (0.25) | (0.25) |
Net Current Asset Value |
5.47 | 23.91 | 24.54 | 18.27 | 10.91 | 68.16 | 133.26 | 139.14 | 115.07 | 99.66 |
| Other line items | ||||||||||
Quick Ratio |
13.26 | 41.94 | 37.59 | 20.77 | 9.98 | 33.76 | 24.50 | 12.73 | 7.41 | 10.00 |
Depreciation/Fixed assets |
0.50 | 0.37 | 0.27 | 0.41 | 0.69 | 1.83 | 2.33 | 1.68 | 4.35 | 6.62 |
Cash ROIC |
(25.43%) | (9.32%) | (13.33%) | (16.77%) | (30.99%) | (12.17%) | (10.72%) | (15.08%) | (18.67%) | (17.77%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.46) | (0.66) | (0.60) | (0.59) | (0.70) | (1.52) | (2.34) | (2.27) | (2.12) | (3.28) |
Capex per Share |
(0.01) | (0.03) | (0.06) | (0.04) | (0.01) | (0.01) | (0.01) | 0.00 | (0.01) | (0.01) |
Average Receivables |
— | — | — | 0.19 | 0.19 | 0.24 | 0.25 | — | — | — |
Average Payables |
0.30 | 0.20 | 0.10 | 0.13 | 0.18 | 0.86 | 2.07 | 3.85 | 7.22 | 7.89 |
Average Assets |
5.68 | 19.01 | 29.00 | 23.16 | 16.62 | 49.43 | 130.80 | 183.46 | 218.17 | 355.84 |
Average Common Equity |
5.31 | 18.50 | 28.37 | 22.32 | 15.50 | 40.21 | 101.24 | 136.77 | 127.69 | 108.09 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates